Synthesis and biological evaluation of N-(arysulfanyl)carbonyl analogues of paclitaxel (taxol)

Chemistry and Biodiversity

Volumn 3, Issue 4, 2006, Pages 396-404

  Karliga, Bekir ^a   Schilling, Jennifer K ^b   Kingston, David G I ^b   Bane, Susan ^c   Ravindra, Rudy ^c   Talinli, Naciye ^a  

^a ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c BINGHAMTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,10BETA BIS(ACETOXY) 1,7BETA DIHYDROXY 13ALPHA [[2ALPHA HYDROXY 3 [[[(4 METHOXYPHENYL)SULFANYL]CARBONYL]AMINO] 3 PHENYLPROPANOYL]OXY] 9 OXO 5BETA,20 EPOXYTAX 11 EN 2 YL BENZOATE; 4,10BETA BIS(ACETOXY) 1,7BETA DIHYDROXY 13ALPHA [[2ALPHA HYDROXY 3 [[[(4 METHYLPHENYL)SULFANYL]CARBONYL]AMINO] 3 PHENYLPROPANOYL]OXY] 9 OXO 5BETA,20 EPOXYTAX 11 EN 2 YL BENZOATE; 4,10BETA BIS(ACETOXY) 1,7BETA DIHYDROXY 13ALPHA [[2ALPHA HYDROXY 3 [[[(4 NITROPHENYL)SULFANYL]CARBONYL]AMINO] 3 PHENYLPROPANOYL]OXY] 9 OXO 5BETA,20 EPOXYTAX 11 EN 2 YL BENZOATE; 4,10BETA BIS(ACETOXY) 1,7BETA DIHYDROXY 13ALPHA [[2ALPHA HYDROXY 3 PHENYL 3 [[(PHENYLSULFANYL)CARBONYL]AMINO]PROPANOYL]OXY] 9 OXO 5BETA,20 EPOXYTAX 11 EN 2 YL BENZOATE; BACCATIN III; DACTINOMYCIN; PACLITAXEL; PACLITAXEL DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; OVARY CANCER; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PACLITAXEL; TUBULIN;

EID: 33646264070     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200690043     Document Type: Article

References (18)

1. M. C. Wani, H. L. Taylor, M. E. Wall, P. Coggon, A. T. McPhail, J. Am. Chem. Soc. 1971, 93, 2325.
2. P. B. Schiff, J. Fant, S. B. Horwitz, Nature 1979, 277, 665.
3. E. K. Rowinsky, Annu. Rev. Med. 1997, 48, 353.
4. J. M. Nabholtz, K. Tonkin, M. Smylie, H. J. Au, M. A. Lindsay, J. Mackey, Expert Opin. Pharmacother. 2000, 1, 187.
5. J. Crown, M. O'Leary, Lancet 2000, 355, 1176.
6. D. G. I. Kingston, P. G. Jagtap, H. Yuan, L. Samala, 'Progress in the Chemistry of Organic Natural Products', Eds. W. Herz, H. Falk, G. W. Kirby, Springer, Wien, 2002, Vol. 84, p. 53.
7. F. Guéritte, Curr. Pharm. Des. 2001, 7, 1229.
8. M. L. Miller, I. Ojima, Chem. Record 2001, 1, 195.
9. G. M. Cragg, D. J. Newman, J. Nat. Prod. 2004, 67, 232.
10. J. N. Denis, A. E. Greene, D. Guenard, F. Gueritte-Voegelein, L. Mangatal, P. Potier, J. Am. Chem. Soc. 1988, 110, 5917.
11. R. A. Holton, J. H. Liu, Bioorg. Med. Chem. Lett. 1993, 3, 2475.
12. I. Ojima, I. Habus, M. Zhao, M. Zucco, Y. H. Park, C. M. Sun, T. Brigaud, Tetrahedron 1992, 48, 6985.
13. C. Palomo, A. Arrieta, F. P. Cossío, J. M. Aizpurua, A. Mielgo, N. Aurrekoetxea, Tetrahedron Lett. 1990, 31, 6429.
14. J. L. Kice, R. A. Bartsch, M. A. Danilles, J. Am. Chem. Soc. 1965, 8, 1734.
15. I. Ojima, C. L. Fumero-Oderda, S. C. Kuduk, Z. Ma, F. Kirikae, T. Kirikae, Bioorg. Med. Chem. 2003, 11, 2867.
16. M. Xue, B. H. Long, C. Fairchild, K. Jhonston, W. C. Rose, J. F. Kadow, D. M. Vyas, S. Chen, Bioorg. Med. Chem. 2000, 10, 1327.
17. R. Brieva, J. Z. Crich, C. J. Sih, J. Org. Chem. 1993, 58, 1068.
18. K. G. Louie, B. C. Behrens, T. J. Kinsella, T. C. Hamilton, K. R. Grotzinger, W. M. McKoy, M. A. Winker, R. F. Ozols, Cancer Res. 1985, 45, 2110.